We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Copeptin in Aortic Valve Replacement (CARE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01648647
First Posted: July 24, 2012
Last Update Posted: July 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen
  Purpose
Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Condition
Copeptin in Patients Undergoing Aortic Valve Replacement

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: GE DHM-AN-OR-2012/01

Resource links provided by NLM:


Further study details as provided by Deutsches Herzzentrum Muenchen:

Enrollment: 50
Study Start Date: May 2012
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients scheduled for surgical or transcatheter aortic valve replacement
Criteria

Inclusion Criteria:

  • Patients undergoing surgical aortic valve replacment
  • Patients undergoing transcatheter aortic valve replacment

Exclusion Criteria:

  • denial by patient
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01648647


Locations
Germany
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany, D80636
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
  More Information

Responsible Party: Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier: NCT01648647     History of Changes
Other Study ID Numbers: GE DHM-AN-OR-2012/01
First Submitted: July 20, 2012
First Posted: July 24, 2012
Last Update Posted: July 24, 2012
Last Verified: July 2012

Additional relevant MeSH terms:
Diabetes Insipidus
Kidney Diseases
Urologic Diseases
Pituitary Diseases
Endocrine System Diseases


To Top